ARCTURUS THERAPEUTICS HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.32 USD | -4.78% |
|
-19.11% | -16.52% |
Chart calendar Arcturus Therapeutics Holdings Inc.
1d064a3680392ed2bee7c.9BNMD7jY32IPLPU0YZgv0bZgKIa5uDzmBhBzmKxkhQI.pislVs6gtgdkGMJfN6humdg0RvHY53O_X3lKqd0CtlSuZSlsiI--UmRGhg~e42975f4f3243de955b93718e014945a
Upcoming events on Arcturus Therapeutics Holdings Inc.
Past events on Arcturus Therapeutics Holdings Inc.
| 2024-03-14 11:45 am | Barclays Global Healthcare Conference - Fireside Chat |
| 2024-03-07 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-07 04:01 pm | Q4 2023 Earnings Release |
| 2024-02-07 09:30 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-09 06:00 pm | JPMorgan Healthcare Conference |
| 2023-11-28 08:30 am | Piper Sandler Healthcare Conference |
| 2023-11-14 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-14 04:01 pm | Q3 2023 Earnings Release |
| 2023-11-07 09:10 am | Guggenheim Securities Inflammation & Immunology Conference |
| 2023-11-01 05:42 am | International mRNA Health Conference |
| 2023-10-01 | Chardan Genetic Medicines Conference |
| 2023-09-27 10:55 am | Cantor Global Healthcare Conference |
| 2023-09-12 03:10 pm | Baird Global Healthcare Conference |
| 2023-09-11 08:30 am | H.C. Wainwright Global Investment Conference |
| 2023-09-07 01:30 pm | Wells Fargo Healthcare Conference |
| 2023-09-06 04:20 pm | Citi BioPharma Conference |
| 2023-08-09 09:30 am | Canaccord Genuity Growth Conference |
| 2023-08-07 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-07 04:01 pm | Q2 2023 Earnings Release |
| 2023-06-14 12:00 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,8 21,7 -4.14% | 9,54 9,74 -2.02% | 12,4 21,3 -42.08% | 206 140 47.16% | 170 174 -2.23% | 147 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -202 -202 -0.07% | 13,7 -60,9 122.49% | -72,1 -106 31.69% | -36,2 |
|
EBIT Million USD | Released Forecast Spread | -25,5 -22,5 -13.45% | -71,5 -63,0 -13.54% | -203 -209 3.17% | 12,2 -67,7 117.99% | -75,1 -88,2 14.93% | -78,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,0 -22,8 -14.14% | -72,1 -63,6 -13.47% | -204 -210 3.07% | 10,6 -67,4 115.79% | -24,8 -37,2 33.41% | -72,0 |
|
Net income Million USD | Released Forecast Spread | -26,0 -22,8 -14.14% | -72,1 -63,5 -13.69% | -204 -211 3.62% | 9,35 -67,4 113.86% | -26,6 -42,5 37.36% | -68,3 |
|
EPS USD | Released Forecast Spread | -2,15 -1,80 -19.56% | -3,55 -3,08 -15.4% | -7,74 -7,90 2% | 0,35 -2,99 111.7% | -1,00 -1,78 43.95% | -2,61 |
| Announcement Date | 11/03/20 | 01/03/21 | 28/02/22 | 28/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,79 11,6 -50.25% | 5,24 7,08 -25.96% | 27,1 3,14 763.69% | 13,4 4,09 226.68% | 160 80,5 99.08% | 80,3 60,5 32.68% | 10,5 49,3 -78.67% | 45,1 15,9 184.53% | 34,0 37,9 -10.25% | 18,6 | 27,5 | 48,7 | 57,0 | 74,7 |
|
EBITDA Million USD | Released Forecast Spread | -14,3 -57,4 75.07% | -43,8 | -18,7 | -19,8 | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -37,6 -47,4 20.51% | -50,4 -38,3 -31.37% | -22,1 -48,7 54.64% | -36,8 -47,7 22.91% | 121 27,3 344.94% | 14,8 -4,63 418.5% | -55,4 -10,1 -449.24% | -19,3 -45,7 57.78% | -15,1 -23,8 36.4% | -37,8 | -27,9 | -13,8 | -5,69 | 8,24 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -38,7 -45,0 14.15% | -51,2 -34,8 -46.85% | -21,6 -49,4 56.39% | -35,3 -45,8 23.05% | 119 40,5 193.16% | 50,9 16,2 213.35% | -52,0 -5,30 -880.64% | -15,3 -44,6 65.64% | -8,31 -15,9 47.77% | -34,7 | -26,8 | -11,3 | -4,13 | 8,09 |
|
Net income Million USD | Released Forecast Spread | -38,7 -46,2 16.39% | -51,2 -34,6 -47.69% | -21,6 -49,4 56.39% | -35,3 -45,8 22.98% | 117 40,5 190.06% | 50,8 18,8 170.59% | -52,6 -4,34 -1110.48% | -16,2 -43,9 63.07% | -8,57 -21,4 60.01% | -32,8 | -27,1 | -11,6 | -4,98 | 1,08 |
|
EPS USD | Released Forecast Spread | -1,47 -1,63 9.57% | -1,94 -1,31 -48.37% | -0,82 -1,86 55.85% | -1,33 -1,77 24.81% | 4,33 1,10 294.53% | 1,87 0,41 353.88% | -1,98 -0,17 -1039.57% | -0,61 -1,65 62.97% | -0,32 -0,99 67.74% | -1,23 | -0,96 | -0,31 | -0,03 | 0,02 |
| Announcement Date | 28/02/22 | 09/05/22 | 09/08/22 | 09/11/22 | 28/03/23 | 09/05/23 | 07/08/23 | 14/11/23 | 07/03/24 | - | - | - | - | - |
More events
Past sector events for Arcturus Therapeutics Holdings Inc.
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ARCT Stock
- Calendar Arcturus Therapeutics Holdings Inc.
